CIK 0001720580 · Non-accelerated filer<br>Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813305277
- Phone
- 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-05 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +336,911 | 336,911 | ||
| 2024-06-05 | Galimi Francesco SVP & Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +375,077 | 375,077 | ||
| 2024-06-05 | Harvey Brian Nicholas Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +374,829 | 374,829 | ||
| 2024-06-05 | Healey Don Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +271,595 | 271,595 | ||
| 2024-06-05 | Schor Chen President & CEO | Grant or award · Stock Option (Right to Buy) | +1,770,427 | 1,770,427 | ||
| 2024-06-05 | GORDON CARL L Director | Grant or award | +5,900 | 11,800 | ||
| 2024-06-05 | GORDON CARL L Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2024-06-05 | Chodakewitz Jeffrey Director | Grant or award | +5,900 | 11,800 | ||
| 2024-06-05 | Chodakewitz Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2024-06-05 | Jakobovits Aya Director | Grant or award | +5,900 | 11,800 | ||
| 2024-06-05 | Jakobovits Aya Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2024-06-05 | DUBIN STEVE Director | Grant or award | +5,900 | 16,800 | ||
| 2024-06-05 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2024-06-05 | Kauffman Michael Director | Grant or award | +5,900 | 11,800 | ||
| 2024-06-05 | Kauffman Michael Director | Sale | −5,900 | $1.43 | $8K | 5,900 |
| 2024-06-05 | Kauffman Michael Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2024-06-05 | Peng Katie Director | Grant or award | +5,900 | 5,900 | ||
| 2024-06-05 | Peng Katie Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2024-06-05 | Sinclair Andrew Director | Grant or award | +5,900 | 11,800 | ||
| 2024-06-05 | Sinclair Andrew Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 |
Page 6 of 15 · 298 trades